Skip to main content

Table 2 Metachronous GA and details

From: Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma

No

Age

Sex

PGL pathology

Lugano stage

Tx for PGL

Interval (months) from PGL to GA

GA pathology

Stage for GA

Tx for GA

Outcome

1

72

F

DLBCL

II1

CHOP×3

42.6

sig

m

distal gastrectomy

Alive for 3.7 m after GA

+

40 Gy/20fr

2

62

M

DLBCL

I

CHOP×3

64.3

W/D AC

m

ESD

Alive for 47.7 m after GA

+

40.5 Gy/27fr

3

70

M

DLBCL

II1

CHOP×3

45.9

W to M/D AC

m

ESD

Alive for 71.6 m after GA

+

40.5 Gy/27fr

4

68

F

DLBCL

I

CHOP×3

90.8

W/D AC

m

ESD

Alive for 31.8 m after GA

+

40.5 Gy/27fr

5

70

M

DLBCL

II1

CHOP×3

16.0

W/D AC

sm

EMR→partial gastrectomy

Dead for 36.9 m after GA

+

40.5 Gy/27fr

6

63

M

DLBCL

IV

R×8-CHOP×8

30.2

W to P/D AC

se

total gastrectomy

Dead for 12.0 m after GA

+

40.5 Gy/27fr

7

36

M

MALT

II1

R×8-CHOP×3

42.1

sig

m

partial gastrectomy

Alive for 20.6 m after GA

+

+

DLBCL

40 G y/20fr

8

63

M

DLBCL

II1

R×8-CHOP×6

73.7

sig

m

EMR

Alive for 16.6 m after GA

+

40.5 Gy/27fr

9

66

F

MALT

II1

CHOP×3

17.5

sig

m

EMR

Alive for 69.3 m after GA

+

+

DLBCL

40.5 Gy/27fr

10

73

F

MALT

I

CHOP×4

7.9

W/D AC

m

EMR

Alive for 70.2 m after GA

+

+

   

DLBCL

 

40.5 Gy/27fr

     
  1. sig: signet-ring cell carcinoma.
  2. W/D: well differentiated.
  3. M/D: moderately differentiated.
  4. P/D: poorly differentiated.
  5. AC: adenocarcinoma.
  6. PGL: primary gastric lymphoma.
  7. R: rituximab.
  8. Tx: treatment.
  9. GA: gastric adenocarcinoma.
  10. CHOP: cyclophosphamide, hydroxydaunorubicin, vincristine and prednisolone.